# Research Progress on the Regulatory Effect of Curcumin on Mesenchymal Stem Cells

**Authors:** Lei Sun, Die Hu, Xinyu Dong, Ruihua Wang, Wei He, Yunjian Pan, Pingjie Li, Xuekun Xing

PMC · DOI: 10.3390/ijms27021015 · International Journal of Molecular Sciences · 2026-01-20

## TL;DR

This paper reviews how curcumin, a compound from turmeric, affects mesenchymal stem cells, highlighting its potential in regenerative medicine and the challenges in its clinical use.

## Contribution

The paper provides a detailed analysis of curcumin's molecular mechanisms in regulating mesenchymal stem cells, supported by experimental evidence.

## Key findings

- Curcumin promotes mesenchymal stem cell proliferation and inhibits apoptosis via signaling pathways and gene modulation.
- It directs differentiation into osteoblasts and chondrocytes while inhibiting adipocyte differentiation.
- Current research faces challenges like low bioavailability and limited in vivo studies.

## Abstract

Curcumin is the main active ingredient in Curcuma longa turmeric, with a wide range of biological effects. It shows significant therapeutic potential in the field of stem cell therapy. This article aims to explore the modulatory effects and underlying mechanisms of curcumin on mesenchymal stem cells (MSCs), providing a theoretical basis based on experimental evidence for its clinical application in regenerative medicine. First, the physicochemical properties, main pharmacological activities, and metabolic pathways of curcumin are described. Subsequently, the key molecular mechanisms by which curcumin regulates MSCs are analyzed in depth, demonstrating that curcumin can significantly promote MSC proliferation and inhibit apoptosis by modulating signaling pathways and gene expression. Additionally, curcumin directs the differentiation of MSCs into osteoblasts and chondrocytes. It also inhibits their differentiation into adipocytes, thereby regulating the physiological functions of MSCs such as proliferation, differentiation, and apoptosis. Finally, several main challenges in current research are highlighted. These include the low oral bioavailability of curcumin; the regulatory effects that vary depending on doses and microenvironmental conditions; the underlying mechanisms not being fully elucidated; the research being mostly limited to in vitro cell models and animal experiments; and the lack of quality standards and production process control systems for curcumin preparations.

## Linked entities

- **Chemicals:** curcumin (PubChem CID 969516)
- **Species:** Curcuma longa (taxon 136217)

## Full-text entities

- **Chemicals:** Curcumin (MESH:D003474)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12842366/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12842366/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12842366/full.md

---
Source: https://tomesphere.com/paper/PMC12842366